• About
• Latest Posts
• Latest Blog Posts
• Boards Posted On
• Boards Moderating

hoops

Send Private Message

Follow Member

Block Messages

Ignore This User

Displaying 951-1000 of 1232 result(s).

Board Name	Posts By hoops	Post Created
GNBTQ Generex Biotechnology Corp.	tc, this is what I don't understand	07/19/2019 10:35:24 AM
GNBTQ Generex Biotechnology Corp.	Does this put an end to all the "de (3)	07/19/2019 10:14:20 AM
GNBTQ Generex Biotechnology Corp.	OJ, why would the market respond on	07/16/2019 2:25:15 PM
GNBTQ Generex Biotechnology Corp.	https://www.google.com/search?clie	07/16/2019 8:51:01 AM
GNBTQ Generex Biotechnology Corp.	Although I can appreciate the senti	07/16/2019 8:31:31 AM
GNBTQ Generex Biotechnology Corp.	Nice find, tc. “Proprietary bucca	07/15/2019 4:26:00 PM
GNBTQ Generex Biotechnology Corp.	I hear you. It's been a long time s	07/15/2019 1:27:59 PM
GNBTQ Generex Biotechnology Corp.	doc, any way to measure the respons	07/15/2019 9:41:37 AM
GNBTQ Generex Biotechnology Corp.	Joe said during the CC, they would (2)	07/12/2019 9:32:18 AM
GNBTQ Generex Biotechnology Corp.	Crazy! .35 spread between bid and a (1)	07/11/2019 10:22:37 AM
GNBTQ Generex Biotechnology Corp.	Although Pantheon seems to focus on	07/11/2019 10:15:46 AM
GNBTQ Generex Biotechnology Corp.	Pantheon Medical Foot and Ankle acq	07/11/2019 9:38:04 AM
GNBTQ Generex Biotechnology Corp.	https://seekingalpha.com/pr/175690 (1)	07/11/2019 9:32:25 AM
GNBTQ Generex Biotechnology Corp.	Didn't Joe reference this in his fi	07/11/2019 8:41:09 AM
GNBTQ Generex Biotechnology Corp.	Good find, tc. Let's not forget tha	07/10/2019 4:58:06 PM
GNBTQ Generex Biotechnology Corp.	I think you will get a tidbit PR so (1)	07/09/2019 7:50:39 PM
GNBTQ Generex Biotechnology Corp.	Unless your intention was to buy sh	07/09/2019 4:56:07 PM
GNBTQ Generex Biotechnology Corp.	Given performance over the past yea	07/09/2019 2:03:34 PM
GNBTQ Generex Biotechnology Corp.	I put in an order for 2.64. It didn	07/09/2019 12:24:16 PM
GNBTQ Generex Biotechnology Corp.	OJ, this is not a big dump. This is	07/08/2019 12:02:16 PM
GNBTQ Generex Biotechnology Corp.	Since we're talking math, GNBT was	07/05/2019 2:12:04 PM
GNBTQ Generex Biotechnology Corp.	OJ, I agree with everything tc said	07/05/2019 11:34:40 AM
GNBTQ Generex Biotechnology Corp.	52 week high-3.27. Hard to come up (1)	07/05/2019 10:27:36 AM
GNBTQ Generex Biotechnology Corp.	Just pennies short of the $3.10 hig	07/03/2019 11:54:22 AM
GNBTQ Generex Biotechnology Corp.	Thanks, Joe. I don’t remember any	07/02/2019 6:40:17 PM
GNBTQ Generex Biotechnology Corp.	Appreciate your enthusiasm. Howeve	07/02/2019 1:19:14 PM
GNBTQ Generex Biotechnology Corp.	I hate giving credence to "she who	07/02/2019 11:25:45 AM
GNBTQ Generex Biotechnology Corp.	Thanks, rj. I'm constantly reminded	07/02/2019 11:15:50 AM
GNBTQ Generex Biotechnology Corp.	Possible source of future funding?	07/02/2019 10:59:01 AM
GNBTQ Generex Biotechnology Corp.	????????? Would a company like Dono (1)	07/02/2019 10:51:28 AM
GNBTQ Generex Biotechnology Corp.	From Donohoe Advisory website: " Co	07/02/2019 10:31:16 AM
GNBTQ Generex Biotechnology Corp.	https://www.donohoeadvisory.com/	07/02/2019 9:49:40 AM
GNBTQ Generex Biotechnology Corp.	Well done, MMPJoe. I know nothing a	07/02/2019 9:41:30 AM
GNBTQ Generex Biotechnology Corp.	Uplisting has been discussed on our	06/28/2019 9:36:01 AM
GNBTQ Generex Biotechnology Corp.	Over the month of June the pps move	06/28/2019 9:30:10 AM
GNBTQ Generex Biotechnology Corp.	Good points, tc. Small biotechs hav (1)	06/26/2019 12:31:19 PM
GNBTQ Generex Biotechnology Corp.	Apparently that's what's happening,	06/26/2019 11:26:03 AM
GNBTQ Generex Biotechnology Corp.	Initially the MM's were making it d	06/26/2019 10:41:08 AM
GNBTQ Generex Biotechnology Corp.	Shares must be very tight. The MM's	06/26/2019 9:55:33 AM
GNBTQ Generex Biotechnology Corp.	doc, you beat me in posting on the	06/26/2019 9:53:46 AM
GNBTQ Generex Biotechnology Corp.	Glad you're on the board today, tc.	06/26/2019 9:50:39 AM
GNBTQ Generex Biotechnology Corp.	Just beat you, doc. I already poste	06/26/2019 9:30:00 AM
GNBTQ Generex Biotechnology Corp.	https://seekingalpha.com/pr/175563	06/26/2019 9:27:03 AM
GNBTQ Generex Biotechnology Corp.	Questions? Eventually will we own s	06/25/2019 6:00:19 PM
GNBTQ Generex Biotechnology Corp.	I don't think the NGIO spin-off or	06/25/2019 11:56:14 AM
GNBTQ Generex Biotechnology Corp.	Right To Try Act https://www.fda.go	06/25/2019 11:01:49 AM
GNBTQ Generex Biotechnology Corp.	OJ, the PR only referenced the merg	06/25/2019 10:46:22 AM
GNBTQ Generex Biotechnology Corp.	These immunotherapy technologies ar	06/25/2019 10:28:26 AM
GNBTQ Generex Biotechnology Corp.	Sorry doc, didn't see your post. Sh (1)	06/25/2019 9:49:48 AM
GNBTQ Generex Biotechnology Corp.	https://seekingalpha.com/pr/175547	06/25/2019 9:39:21 AM

• Next >

54875505487511548471454842565484213548389054837245483409548191354810645481055548097154809635480886548058154797615479648547947954793505478407547713254769885476898547598454755595475300547514954751305475101547509354750525474970547495554724095472391547072854706375470570547050754705045470498547046654704555470026546968354696355469617546958854695225469504

Recent Articles

• Neos Corporation Unveils Enhanced Crayon Shin-chan App for iOS
• CoinEx Charity's Starlink Initiative Transforms Connectivity
• Zai Lab Boosts Patient Access to AUGTYRO for Lung Cancer
• Recursive Teams Up with Saudi Arabia for AI-Powered TB Solutions
• Akeso's Cadonilimab and Ivonescimab Added to National Drug List
• TeamT5 Earns Prestigious Recognitions in Cybersecurity Innovation
• Innovent Biologics Adds SINTBILO and Olverembatinib to NRDL
• Genesis Lifestyle Medicine Recognized for Stellar Leadership Achievement
• Genesis Lifestyle Medicine Earns Certified Amazing Workplace Honor
• Bridging Cultures: China and Europe's River Dialogues
• The Surge in Population Health Management: A $663.75 Billion Future
• Prime Mining Releases New Technical Report on Los Reyes Project
• Investigation Announced for Symbotic Inc. Shareholders
• Monument Mining Limited Reports Positive Q1 FY 2025 Results
• Strategic Alliance Between Sumitomo and Rikkeisoft Ignites Growth
• Innovative Approaches to Combat the Fall Armyworm Crisis
• Exro Technologies Faces Potential Class Action Suit
• BioArctic's Leqembi®: A New Hope for Alzheimer's Patients
• BioArctic Partners with Eisai for Leqembi Launch in Asia
• Rakovina Therapeutics Unveils New Financial Strategy for Growth
• Nonwoven Filtration Market Expected to Hit $8.4 Billion by 2028
• AIP Realty Trust Reports Q3 Financial Progress and Future Growth
• Weave Living and KKR Form Joint Venture to Enhance Japan's Housing Market
• Celsius Holdings Faces Legal Challenges—What Investors Should Know
• Lomiko Metals Secures Funding for La Loutre Graphite Project
• U.S. Gold Corp. Launches Significant $10.2 Million Offering
• Key Insights into the Growth of the Medical Nonwoven Market
• Exploring the Growth of the Portable Power Station Market
• Investors Alert: Class Action Update on Edwards Lifesciences
• Casio Unveils Iconic DW-5000R, A Nod to G-SHOCK Heritage
• Casio Unveils New DW-5000R, Reviving G-SHOCK's Legacy
• American Lithium's Annual Meeting Highlights and Future Plans
• Rentokil Initial PLC Faces Class Action Claims - Key Insights
• Significant Jury Victory for Guardant Health Against Natera
• Robbins LLP Highlights Class Action Opportunities for AILE Investors
• Legal Update: Dentsply Sirona Inc. Class Action Notification
• Exploring Growth within the Animal Feed Additives Industry
• Women’s Watch Market Set for Significant Growth by 2031
• Eisai and Biogen Launch LEQEMBI for Alzheimer's in New Markets
• Patterson Companies to Host Second Quarter Conference Call
• Metafy Partners with Lucky Kat to Enhance Kumo Brand Growth
• Projection of US$ 3.6 Billion in Aircraft Cabin Composites
• Explore the Galaxy with $DUKE: The New Meme Coin Sensation
• Understanding the Recent Distribution Notification from SABA Fund
• Saba Capital Income Fund Shares Distribution Insights
• Exploring the Strength of US-China Supply Chain Collaboration
• Expand Energy Corporation Completes Tender Offer for Senior Notes
• Brookfield Infrastructure Shares Buyback Plans Engage Investors
• Revolutionizing Work with Hyundai and Kia's New Wearable Robot
• First Horizon Appoints Tyler Craft as New Investor Relations Head